Searchable abstracts of presentations at key conferences in endocrinology

ea0090p603 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Strategic Designs to identify the best housekeeping genes for the characterization of biomarkers in adipose tissue of patients with obesity and cancer

Perez Gomez Jesus , Porcel-Pastrana Francisco , de la Luz Borrero Marina , Gahete Manuel D. , Guzman Rocio , Malagon Maria , Luque Raul M.

Obesity (OB) is caused by an energy imbalance that finally leads to adipose tissue dysfunction, and the appearance of multiple comorbidities, such as certain cancer types, including prostate cancer (PCa), which is one of the leading causes of cancer-related death in men population worldwide. In this context, periprostatic adipose tissue (PPAT) has recently gained increased attention as a key regulator of the pathophysiological relationship between OB and PCa. However, it has b...

ea0081p132 | Endocrine-Related Cancer | ECE2022

Somatostatin receptor splicing variant SST5TMD4 overexpression in glioblastoma is associated to poor survival, increased aggressiveness features and somatostatin analogs resistance

Perez Gomez Jesus , Fuentes-Fayos Antonio C. , G-Garcia Miguel E. , Peel Annabel , Blanco Acevedo Cristobal , Solivera Vela Juan , Ibanez Costa Alejandro , David Gahete Ortiz Manuel , Castano Justo P. , Luque Raul M.

Glioblastoma (GBM; grade IV astrocytoma) is the one of the most malignant and lethal endocrine-related cancers worldwide. Current standard treatment consists of surgery followed by radiotherapy and/or chemotherapy; however, this is only a palliative approach with a mean post-operative survival of scarcely ~12-15 months. Therefore, the identification of novel therapeutic targets to treat this devastating pathology is urgently needed. In this context, the truncated splicing-vari...

ea0075r08 | Reproductive Endocrinology | EYES2021

Unveiling the therapeutic role of somatostatin and cortistatin in prostate cancer

Perez-Gomez Jesus M. , Saez-Martinez Prudencio , Jimenez-Vacas Juan M. , Herrero-Aguayo Vicente , Pedraza-Arevalo Sergio , Gomez-Gomez Enrique , Leon-Gonzalez Antonio J. , Castano Justo P. , Martinez-Fuentes Antonio J. , Gahete Manuel D. , Luque Raul M.

Background: Somatostatin (SST)/Cortistatin (CORT) system is a complex hormonal axis involved in the progression of several tumor types. However, its role has not been explored in prostate cancer (PCa), one of the most common type among men.Objectives: We aimed to investigate the presence and the pathophysiological role of SST/CORT in PCa.Methods: We analysed functional parameters in response to SST and CORT and to CORT-silencing in...

ea0075o08 | Obesity, metabolism & miscellaneous endocrinology | EYES2021

Additive antitumor effect of metformin and simvastatin combination in glioblastoma: evidence for a potential drug repurposing

Fuentes-Fayos Antonio C. , Perez-Gomez Jesus M. , Garcia-Garcia Miguel E. , Jimenez-Vacas Juan M. , Martin-Colom Julia , Doval-Rosa Carlos , Blanco-Acevedo Cristobal , Gahete Manuel D. , Castano Justo P. , Solivera Juan , Luque Raul M.

Background: Glioblastomas (GBMs) remain the deadliest human brain tumors, with a poor prognosis despite years of research. Currently, standard therapeutic strategies to treat GBM are not efficient, and the overall survival is ˜14 months. Thus, the identification of new therapeutic tools to battle GBMs is crucial. In this sense, many metabolic drugs (e.g., metformin (MF) and simvastatin (SVT)) have emerged as putative antitumor agents for certain endocrine-related cancers,...

ea0090p383 | Endocrine-related Cancer | ECE2023

MiR-191-5p represents a potential personalized diagnostic and therapeutic tool for PCa patients, especially in obesity conditions

Porcel-Pastrana Francisco , Herrero-Aguayo Vicente , Saez-Martinez Prudencio , M Jimenez-Vacas Juan , Perez Gomez Jesus , Montero-Hidalgo Antonio J. , Carrasco-Valiente Julia , Lopez-Miranda Jose , Anglada Francisco J. , Gomez-Gomez Enrique , Sarmento-Cabral Andre , Gahete Manuel D. , Luque Raul M.

Prostate cancer (PCa) is one of the most common causes of cancer-related deaths in men worldwide. Therefore, more specific non-invasive diagnostic biomarkers with potential therapeutic use are urgently needed. As miRNAs have been proposed as promising elements for the identification of novel diagnostic and therapeutic tools for different pathologies, including different cancer types, we investigated herein the miRNA landscape in PCa patients and explored their putative diagnos...

ea0063oc5.3 | Adrenal 1 | ECE2019

SF3B1 as novel target for the treatment of multiple endocrine-related cancers

Jimenez-Vacas Juan M , Lopez-Canovas Juan L , Vazquez-Borrego Mari C , Pedraza-Arevalo Sergio , del Rio-Moreno Mercedes , Herrero-Aguayo Vicente , Saez-Martinez Prudencio , Montero-Hidalgo Antonio J , Encinas Ricardo Blazquez , Lara-Lopez Araceli , Perez-Gomez Jesus M , Gomez-Gomez Enrique , Herrera-Martinez Aura , Gadelha Monica R , Castano Justo P , Gahete Manuel D , Luque Raul M

The intrinsic heterogeneity of endocrine-related cancers (ERCs) hampers the identification and development of global and effective therapeutic treatments for these pathologies. However, the dysregulation of the splicing process has been postulated as a new common hallmark shared by most cancer types, since it is associated with the appearance of splicing variants with oncogenic potential (e.g. CD44v6, BCL-Xs, AR-v7, SST5TMD4, In1-ghrelin...

ea0070aep529 | Endocrine-related Cancer | ECE2020

An Endocrine and metabolic interactomic approach to identify novel diagnostic/prognostic biomarkers and therapeutic targets in gliomas

Perez Gomez Jesus , Fuentes-Fayos Antonio C. , GandiÌa-GonzaÌlez Marisa L. , Cano-Rojas Alberto , Blanco-Acevedo Cristóbal , Negro-Moral Eva M. , Toledano AÌlvaro , Ramos Manuel J. , Ortega-Salas Rosa M. , CerdaÌn Sebastián , GarciÌa-MartiÌn Marisa L. , Luque Raúl M. , Solivera Juan

Gliomas are a common tumor type that affects the glial cells with common features of malignant tumors such as aggressive invasiveness, malignant transformation and vascular proliferation through the central nervous system. Currently, standard therapeutic strategies to treat malignant gliomas are not efficient having alow-rate survival (~12 months). Hence, there is a clear necessity for the identification of novel diagnostic/prognostic tools and therapeutic strategies to m...